Non-Invasive Prenatal Testing market was valued at US$ 5472.5 million in 2022 and is anticipated to reach US$ 10060 million by 2029, witnessing a CAGR of 10.7% -Valuates Reports

The global Non-Invasive Prenatal Testing market was valued at US$ 5472.5 million in 2022 and is anticipated to reach US$ 10060 million by 2029, witnessing a CAGR of 10.7% during the forecast period 2023-2029.

Get sample Report - https://reports.valuates.com/request/sample/QYRE-Auto-29Y3959/Global_Non_Invasive_Prenatal_Testing_Market_Insights_and_Forecast_to_2028

Non-Invasive Prenatal Testing Market Major Trends
Improvements in the reimbursement environment and increased demand for early Non-Invasive Prenatal Testing (NIPT) are two factors that are projected to propel market expansion over the forecast period. Due to the variance in contracts, noninvasive prenatal test reimbursement differs between insurance plans.

Non-Invasive Prenatal Testing Market Trends
The rise in the prevalence of chromosomal aneuploidies in fetuses, the introduction of improved non-invasive parenteral testing devices, and improvements in the reimbursement environment are the key causes of the growth in the non-invasive prenatal testing (NIPT) industry. Additionally, growing consumer awareness of non-invasive prenatal testing and unexplored market potential in Asia's emerging nations present considerable chances for revenue growth for market participants.

Due to a number of variables, including an increase in doctors preferring advanced genetic testing for high-risk pregnancies, a desire to delay childbearing, and an increase in pregnancy-related issues in the third or second trimester, NIPT is becoming more and more in demand worldwide. As a result, there is a significant need for tests that are more effective, noninvasive, and safe, and a fall in the use of these procedures. For the identification of frequently occurring trisomies in the foetus, such as Turner syndrome, Down syndrome, foetal rhesus D status, and sex chromosomal disorders, as well as for foetal sex determination, NIPT uses cell-free foetal DNA (cffDNA) that circulates in the mother's blood. This in turn is expected to drive the growth of the Non-Invasive Prenatal Testing market.

Prenatal testing is shifting towards non-invasive techniques so that the danger of miscarriage is reduced while still determining the foetal risk for genetic diseases. Novel screening techniques for foetal chromosomal aneuploidies have been developed as a result of advances in modern molecular technology and the identification of cell-free foetal DNA in maternal plasma. Chromosomal aberrations can now be found using NGS technology and cffDNA analysis thanks to its higher throughput and lower cost. Because more people are becoming aware of the benefits of non-invasive techniques, there has been a continuous increase in the development of new technology for NIPT.

Gynecologists and patients' increasing preference for using diagnostic laboratories' NIPT services reflects this end-user segment's leading position in the NIPT market as a whole in 2019. A higher volume of tests is now being outsourced to diagnostic labs due to the availability of well-equipped facilities and competent laboratory workers, which is driving a larger proportion of this market. Moreover, the expansion of the NIPT market among diagnostic labs is anticipated to be supported by the rising number of initiatives taken by diagnostic laboratories to deliver safe and reliable prenatal testing over the forecast period.

Non-Invasive Prenatal Testing Market Share Analysis
Throughout the projection period, North America is anticipated to have a dominant position in the non-invasive prenatal testing (NIPT) market. The adoption and demand for testing in this area will probably rise as a result of the region's high rates of preterm delivery, high rates of maternal death, and rising rates of chromosomal abnormalities.

Get sample report - https://reports.valuates.com/market-reports/QYRE-Auto-29Y3959/global-non-invasive-prenatal-testing

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs

This release was published on openPR.